Published in Nat Rev Neurol on March 18, 2016
Zika virus: An update on epidemiology, pathology, molecular biology, and animal model. J Med Virol (2016) 1.02
Exosomes in Viral Disease. Neurotherapeutics (2016) 0.76
Vaccinations for Neuroinfectious Disease: A Global Health Priority. Neurotherapeutics (2016) 0.75
Zika Virus and Guillain-Barre Syndrome: Is There Sufficient Evidence for Causality? Front Neurol (2016) 0.75
CD8(+) T Cell Immune Response in Immunocompetent Mice during Zika Virus Infection. J Virol (2017) 0.75
An inexpensive Arduino-based LED stimulator system for vision research. J Neurosci Methods (2012) 1.40
Effects of the kainate receptor agonist ATPA on glutamatergic synaptic transmission and plasticity during early postnatal development. Neuropharmacology (2007) 0.82
Alzheimer disease: Variations in mitochondrial DNA predict AD-related brain atrophy. Nat Rev Neurol (2013) 0.80
Dementia: Vascular comorbidities linked with early-onset dementia. Nat Rev Neurol (2014) 0.80
Trial Watch: Glioblastoma vaccine therapy disappointment in Phase III trial. Nat Rev Neurol (2016) 0.79
Neurodevelopmental disorders: human gut microbiota alleviate behavioural symptoms in a mouse model of autism spectrum disorder. Nat Rev Neurol (2013) 0.78
Parkinson disease: deep brain stimulation might alleviate parkinsonism by reducing excessive synchronization in primary motor cortex. Nat Rev Neurol (2015) 0.78
Ageing: Could young blood combat age-related cognitive decline? Nat Rev Neurol (2014) 0.78
Alzheimer disease: Possible prion-like transmission of AD-like pathology in humans. Nat Rev Neurol (2015) 0.78
Multiple sclerosis: Spinal cord grey matter loss correlates with disability in MS. Nat Rev Neurol (2014) 0.78
Alzheimer disease: Sleep alleviates AD-related neuropathological processes. Nat Rev Neurol (2013) 0.78
Epilepsy-burning questions and emerging therapies. Nat Rev Neurol (2014) 0.77
Alzheimer disease: APOE*ε4-associated increase in AD risk linked to phospholipid dysregulation. Nat Rev Neurol (2015) 0.77
Alzheimer disease: The involvement of TREM2 R47H variant in Alzheimer disease confirmed, but mechanisms remain elusive. Nat Rev Neurol (2015) 0.77
Alzheimer disease: chaperone protein clusterin is involved in amyloid-β-associated entorhinal atrophy in early AD. Nat Rev Neurol (2014) 0.77
Alzheimer disease: NGF gene therapy activates neurons in the AD patient brain. Nat Rev Neurol (2015) 0.77
Alzheimer disease: Effects of the APOE ε4 allele on brain development. Nat Rev Neurol (2013) 0.76
Neuro-oncology: Bevacizumab prolongs progression-free survival but not overall survival in newly diagnosed glioblastoma. Nat Rev Neurol (2014) 0.76
Neuro-oncology: Novel biomarkers for high-grade astrocytoma. Nat Rev Neurol (2014) 0.76
Neuro-oncology: TERT promoter mutations could indicate poor prognosis in glioblastoma. Nat Rev Neurol (2014) 0.76
CNS cancer: Astrocytoma cells interconnect to resist radiotherapy. Nat Rev Clin Oncol (2015) 0.75
Huntington disease: New study challenges the hypothesis of glutamate transporter dysfunction in Huntington disease. Nat Rev Neurol (2016) 0.75
Alzheimer disease: NSAIDs protect neurons and preserve memory in a mouse model of AD. Nat Rev Neurol (2016) 0.75
Neuro-oncology: Exercise could help to counteract radiation damage in children with brain tumours. Nat Rev Neurol (2016) 0.75
Alzheimer disease: Cancer immunotherapy drug reduces symptoms of Alzheimer disease in mice. Nat Rev Neurol (2016) 0.75
Epilepsy: Beyond seizure control - vocational outcomes after paediatric epilepsy surgery. Nat Rev Neurol (2016) 0.75
Sleep: Amyloid-β accumulation impairs memory by disrupting deep sleep--but could the vicious cycle be stopped? Nat Rev Neurol (2015) 0.75
Neurodevelopmental disorders: Altered epigenetic regulation in early development associated with schizophrenia. Nat Rev Neurol (2015) 0.75
Parkinson disease: Retinal changes could be an early marker of PD. Nat Rev Neurol (2016) 0.75
Migraine: Long screen time exposure could increase the risk of migraine. Nat Rev Neurol (2015) 0.75
Alzheimer disease: BACE1 inhibition could block CSF tau increase. Nat Rev Neurol (2016) 0.75
Stroke: Gut microbiota influence stroke recovery in mice. Nat Rev Neurol (2016) 0.75
Neurodevelopmental disorders: Fetal exposure to antiepileptic drugs could affect brain activity in newborns. Nat Rev Neurol (2016) 0.75
Neurodevelopmental disorders. Unmuting Ube3a in mice alleviates Angelman syndrome. Nat Rev Neurol (2014) 0.75
Neurodevelopmental disorders: Deep brain stimulation alleviates hippocampal memory deficit in a mouse model of Rett syndrome. Nat Rev Neurol (2015) 0.75
Multiple sclerosis: Worrying data on excess mortality and comorbidity in MS. Nat Rev Neurol (2015) 0.75
Parkinson disease: Could gut microbiota influence severity of Parkinson disease? Nat Rev Neurol (2016) 0.75
Dementia: new study puts its FINGER on prevention of cognitive decline. Nat Rev Neurol (2015) 0.75
Multiple sclerosis: neuroimaging provides insights into cognitive dysfunction in MS. Nat Rev Neurol (2015) 0.75
Neuromuscular disease: Improved diagnostic sensitivity can aid the correct choice of treatment for patients with myasthenia gravis. Nat Rev Neurol (2015) 0.75
Epilepsy: Early treatment could prevent genetic epilepsy in mice. Nat Rev Neurol (2015) 0.75
Multiple sclerosis: Blood-based biomarkers provide insight into progressive MS. Nat Rev Neurol (2014) 0.75
Alzheimer disease: increased orexin level correlates with sleep disruption and cognitive decline in Alzheimer disease. Nat Rev Neurol (2014) 0.75
Migraine: Migraine in midlife could be connected to increased risk of late-life parkinsonism. Nat Rev Neurol (2014) 0.75
Motor Neuron Disease: New insights into genetic risk factors for amyotrophic lateral sclerosis. Nat Rev Neurol (2016) 0.75
Neurodegenerative disease: Synaptic scaffolding protein neuroligin 1 links amyloid deposition, neuroinflammation and impaired memory. Nat Rev Neurol (2014) 0.75
Neurodegenerative disorders: Novel CSF assay for α-synucleinopathies. Nat Rev Neurol (2016) 0.75
Genetics: RNA topoisomerase involved in neurodevelopmental disorders. Nat Rev Neurol (2013) 0.75
Parkinson disease: Nonmotor symptoms predict quality of life in patients with early Parkinson disease. Nat Rev Neurol (2013) 0.75
Neuroimmunology: Aquaporin-4-antibody-seronegative neuromyelitis optica is less common than previously thought. Nat Rev Neurol (2013) 0.75
Multiple sclerosis: could simvastatin slow down secondary progressive MS? Nat Rev Neurol (2014) 0.75
Cerebrovascular disease: Subclinical cerebrovascular disease can impede learning. Nat Rev Neurol (2015) 0.75
Motor neuron disease: High-calorie diet might delay amyotrophic lateral sclerosis. Nat Rev Neurol (2014) 0.75
Neuromuscular disease: Mitochondrial dysfunction could precipitate motor neuron loss in spinal muscular atrophy. Nat Rev Neurol (2016) 0.75
Huntington disease: Selective deactivation of Huntington disease mutant allele by CRISPR-Cas9 gene editing. Nat Rev Neurol (2016) 0.75
Alzheimer disease: Insulin resistance could be linked to risk of AD via reduced glucose uptake. Nat Rev Neurol (2015) 0.75
Traumatic brain injury: PET imaging detects amyloid deposits after TBI. Nat Rev Neurol (2013) 0.75
Motor neuron disease: Brain transcriptome profiling reveals involvement of divergent pathways in C9orf72-associated and sporadic ALS. Nat Rev Neurol (2015) 0.75
Stroke: Alcohol consumption does not seem to protect against stroke. Nat Rev Neurol (2015) 0.75
Motor neuron disease: C9orf72 repeat expansion linked to aggressive disease in male patients with spinal-onset ALS. Nat Rev Neurol (2016) 0.75
Motor neuron disease: Multifocal initiation and local propagation model of ALS. Nat Rev Neurol (2013) 0.75
Neuro-oncology: Mice vaccinated against tumour recurrence. Nat Rev Neurol (2014) 0.75
Multiple sclerosis: Dehydration might contribute to fatigue in MS. Nat Rev Neurol (2016) 0.75
Traumatic brain injury: Impaired medical decision-making capacity in TBI. Nat Rev Neurol (2016) 0.75
CNS infections: Mouse studies confirm the link between Zika virus infection and microcephaly. Nat Rev Neurol (2016) 0.75
Neuro-oncology: Astrocytoma cells interconnect to resist radiotherapy. Nat Rev Neurol (2015) 0.75
Neuro-oncology: Proteomic profiling could facilitate glioblastoma diagnosis. Nat Rev Neurol (2014) 0.75
Headache: Chronic migraine linked to reduced antioxidant capacity. Nat Rev Neurol (2015) 0.75
Cerebrovascular disorders: Cerebral microbleeds linked to increased risk of cognitive decline. Nat Rev Neurol (2016) 0.75
Demyelinating disease: Novel markers for disease severity in neuromyelitis optica. Nat Rev Neurol (2016) 0.75
Neuro-oncology: MET fusion genes implicated as treatment target in paediatric glioblastoma. Nat Rev Neurol (2016) 0.75
Movement disorders: Novel genetic risk variants for essential tremor. Nat Rev Neurol (2016) 0.75
Improved diagnostic sensitivity can aid the correct choice of treatment for patients with myasthenia gravis. Nat Rev Neurol (2015) 0.75
Traumatic brain injury: TBI could have long-term effects on sleep-wake cycle. Nat Rev Neurol (2016) 0.75
Multiple sclerosis: Coagulation factors could mediate neuroinflammation in multiple sclerosis. Nat Rev Neurol (2016) 0.75
Dementia: Declining dementia incidence in the UK. Nat Rev Neurol (2016) 0.75
Cerebrovascular disorders: Exercise alleviates vascular cognitive impairment. Nat Rev Neurol (2016) 0.75
Multiple sclerosis: Biomarkers predict conversion from clinically isolated syndrome to multiple sclerosis. Nat Rev Neurol (2015) 0.75
Neurodevelopmental disorders: Elevated fetal sex steroids might confer risk for autism. Nat Rev Neurol (2014) 0.75
In the news: Highlights from the SfN 2016. Nat Rev Neurol (2016) 0.75
Epilepsy: Metabolic syndrome in young adults with epilepsy. Nat Rev Neurol (2016) 0.75
Neurodevelopmental disorders: Maternal antibodies induce autism-like phenotype in mice. Nat Rev Neurol (2016) 0.75
Neuro-oncology: Long-term outcomes in childhood low-grade glioma. Nat Rev Neurol (2016) 0.75
Neurodevelopmental disorders: Impaired immune system function linked to social behaviour deficits in mice. Nat Rev Neurol (2016) 0.75
Multiple sclerosis: Does low vitamin D level during pregnancy increase the risk of MS? Nat Rev Neurol (2016) 0.75